Charles River Laboratories (CRL) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Charles River Laboratories Revenue Highlights

Latest Revenue (Y)

$4.05B

Latest Revenue (Q)

$1.03B

Main Segment (Y)

Discovery and Safety Assessment

Main Geography (Y)

UNITED STATES

Charles River Laboratories Revenue by Period

Charles River Laboratories Revenue by Year

Date	Revenue	Change
2024-12-28	$4.05B	-1.92%
2023-12-30	$4.13B	3.86%
2022-12-31	$3.98B	12.31%
2021-12-25	$3.54B	21.08%
2020-12-26	$2.92B	11.55%
2019-12-28	$2.62B	15.67%
2018-12-29	$2.27B	21.99%
2017-12-30	$1.86B	10.48%
2016-12-31	$1.68B	23.34%
2015-12-26	$1.36B	5.06%
2014-12-27	$1.30B	11.34%
2013-12-28	$1.17B	3.19%
2012-12-29	$1.13B	-1.15%
2011-12-31	$1.14B	0.81%
2010-12-25	$1.13B	-5.75%
2009-12-26	$1.20B	-10.49%
2008-12-27	$1.34B	9.17%
2007-12-29	$1.23B	16.27%
2006-12-30	$1.06B	-5.69%
2005-12-31	$1.12B	46.33%
2004-12-25	$766.92M	24.96%
2003-12-27	$613.72M	10.65%
2002-12-28	$554.63M	19.11%
2001-12-29	$465.63M	51.88%
2000-12-31	$306.58M	39.82%
1999-12-25	$219.28M	13.44%
1998-12-31	$193.30M	-

Charles River Laboratories generated $4.05B in revenue during NA 2024, up -1.92% compared to the previous quarter, and up 154.51% compared to the same period a year ago.

Charles River Laboratories Revenue by Quarter

Date	Revenue	Change
2024-06-29	$1.03B	1.44%
2024-03-30	$1.01B	-0.19%
2023-12-30	$1.01B	-1.28%
2023-09-30	$1.03B	-3.14%
2023-07-01	$1.06B	2.97%
2023-04-01	$1.03B	-6.41%
2022-12-31	$1.10B	11.19%
2022-09-24	$989.16M	1.65%
2022-06-25	$973.13M	6.48%
2022-03-26	$913.93M	0.98%
2021-12-25	$905.05M	1.02%
2021-09-25	$895.94M	-2.04%
2021-06-26	$914.61M	10.92%
2021-03-27	$824.57M	4.24%
2020-12-26	$790.99M	6.42%
2020-09-26	$743.30M	8.90%
2020-06-27	$682.58M	-3.46%
2020-03-28	$707.06M	2.30%
2019-12-28	$691.14M	3.47%
2019-09-28	$667.95M	1.58%
2019-06-29	$657.57M	8.77%
2019-03-30	$604.57M	0.51%
2018-12-29	$601.53M	2.77%
2018-09-29	$585.29M	-0.00%
2018-06-30	$585.30M	18.49%
2018-03-31	$493.97M	3.24%
2017-12-30	$478.48M	3.07%
2017-09-30	$464.23M	-1.04%
2017-07-01	$469.13M	5.24%
2017-04-01	$445.76M	-4.50%
2016-12-31	$466.79M	9.65%
2016-09-24	$425.72M	-1.92%
2016-06-25	$434.06M	22.31%
2016-03-26	$354.87M	0.29%
2015-12-26	$353.85M	1.25%
2015-09-26	$349.46M	2.91%
2015-06-27	$339.57M	5.98%
2015-03-28	$320.41M	-2.77%
2014-12-27	$329.55M	0.60%
2014-09-27	$327.57M	-3.99%
2014-06-28	$341.18M	13.97%
2014-03-29	$299.37M	3.51%
2013-12-28	$289.23M	-0.99%
2013-09-28	$292.13M	-0.27%
2013-06-29	$292.93M	0.58%
2013-03-30	$291.24M	3.96%
2012-12-29	$280.14M	0.52%
2012-09-29	$278.69M	-2.12%
2012-06-30	$284.72M	-0.44%
2012-03-31	$285.98M	-1.71%
2011-12-31	$290.96M	4.82%
2011-09-24	$277.58M	-3.71%
2011-06-25	$288.26M	0.85%
2011-03-26	$285.84M	6.70%
2010-12-25	$267.89M	-2.97%
2010-09-25	$276.08M	-5.49%
2010-06-26	$292.10M	-1.76%
2010-03-27	$297.35M	0.66%
2009-12-26	$295.38M	-0.71%
2009-09-26	$297.49M	-3.46%
2009-06-27	$308.16M	2.20%
2009-03-28	$301.53M	-3.19%
2008-12-27	$311.45M	-8.99%
2008-09-27	$342.23M	-2.81%
2008-06-28	$352.13M	4.28%
2008-03-29	$337.69M	6.18%
2007-12-29	$318.03M	-

Charles River Laboratories generated $1.03B in revenue during Q2 2024, up 1.44% compared to the previous quarter, and up 99.68% compared to the same period a year ago.

Charles River Laboratories Revenue Breakdown

Charles River Laboratories Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Manufacturing Support	$769.33M	$721.44M	-	-	-
Discovery and Safety Assessment	$2.45B	$2.62B	-	-	-
Research Models and Services	$829.38M	$792.34M	-	-	-
Service	-	$3.44B	$3.22B	$2.76B	$2.30B
Product	-	$689.39M	$759.16M	$784.58M	$627.78M

Charles River Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 24: Discovery and Safety Assessment (60.53%), Research Models and Services (20.48%), and Manufacturing Support (19.00%).

Quarterly Revenue by Product

Product/Service	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Apr 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Discovery and Safety Assessment	$1.23B	$615.06M	$605.45M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Manufacturing Support	$387.25M	$196.88M	$185.20M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product	-	-	$194.70M	$175.47M	$156.86M	$185.05M	$172.01M	$199.15M	$176.26M	$190.30M	$193.44M	$195.23M	$192.08M	$199.29M	$197.99M	$172.76M	$162.53M	$132.02M	$160.47M	$141.76M
Service	-	-	$816.86M	$838.00M	$869.76M	$874.89M	$857.37M	$900.70M	$812.89M	$782.83M	$720.49M	$709.82M	$703.86M	$715.32M	$626.58M	$618.23M	$580.77M	$550.56M	$546.59M	$549.38M

Charles River Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Discovery and Safety Assessment (76.07%), and Manufacturing Support (23.93%).

Charles River Laboratories Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
CANADA	$482.09M	$487.31M	$398.98M	$339.10M	$306.26M
Asia Pacific	$196.95M	$200.83M	$192.84M	$222.90M	-
UNITED STATES	$2.24B	$2.35B	$2.34B	$1.93B	$1.63B
Europe	$1.08B	$1.08B	$1.03B	$1.04B	$829.31M
Other	-	$16.85M	$9.96M	$7.29M	$6.13M
JAPAN	-	-	-	-	$155.09M

Charles River Laboratories's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (56.04%), Europe (26.97%), CANADA (12.06%), and Asia Pacific (4.93%).

Quarterly Revenue by Country

Country	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Apr 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
CANADA	$244.60M	$127.09M	$110.40M	$130.03M	$129.02M	$117.65M	$110.61M	$118.44M	$101.60M	$93.69M	$85.25M	$86.17M	$85.25M	$90.56M	$77.11M	$79.09M	$79.00M	$71.54M	$76.63M	$77.12M
UNITED STATES	$1.12B	$559.28M	$562.32M	$544.95M	$590.32M	$606.77M	$605.44M	$653.43M	$595.26M	$566.92M	$526.55M	$500.74M	$493.56M	$491.62M	$448.48M	$430.54M	$406.98M	$382.92M	$406.71M	$379.90M
Europe	$534.70M	$267.12M	$276.32M	$271.47M	$264.79M	$272.98M	$267.70M	$271.53M	$245.93M	$263.58M	$251.09M	$264.87M	$258.35M	$275.71M	$237.53M	$233.92M	$214.19M	$190.94M	$190.26M	$192.60M
Asia Pacific	$106.17M	$45.01M	$45.77M	$57.92M	$40.23M	$59.86M	$42.81M	$53.85M	$43.80M	$46.24M	$48.95M	$51.72M	$56.61M	$55.13M	$59.45M	$41.55M	$35.97M	$31.83M	-	-
Other	-	-	$16.75M	$9.10M	$2.26M	$2.67M	$2.81M	$2.60M	$2.56M	$2.70M	$2.10M	$1.55M	$2.16M	$1.58M	$2.00M	$1.70M	$1.58M	$1.22M	$1.62M	$1.38M

Charles River Laboratories's latest quarterly revenue breakdown by geography, as of Dec 24: UNITED STATES (55.81%), Europe (26.68%), CANADA (12.21%), and Asia Pacific (5.30%).

Charles River Laboratories Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
IQV	IQVIA	$15.40B	$3.90B
LH	Laboratory Corporation of America	$12.16B	$3.28B
ICLR	ICON Public	$8.12B	$2.09B
A	Agilent	$6.83B	$1.68B
ILMN	Illumina	$4.37B	$1.08B
CRL	Charles River Laboratories	$4.05B	$1.03B
IDXX	IDEXX Laboratories	$3.90B	$975.54M
MTD	Mettler-Toledo	$3.87B	$954.53M
WAT	Waters	$2.96B	$740.30M
RVTY	Revvity	$2.76B	$641.72M
MEDP	Medpace	$2.11B	$533.32M
GH	Guardant Health	$739.02M	$177.24M
CDNA	CareDx	$333.79M	$82.88M

CRL Revenue FAQ

What is Charles River Laboratories’s yearly revenue?

Charles River Laboratories's yearly revenue for 2024 was $4.05B, representing a decrease of -1.92% compared to 2023. The company's yearly revenue for 2023 was $4.13B, representing an increase of 3.86% compared to 2022. CRL's yearly revenue for 2022 was $3.98B, representing an increase of 12.31% compared to 2021.

What is Charles River Laboratories’s quarterly revenue?

Charles River Laboratories's quarterly revenue for Q2 2024 was $1.03B, a 1.44% increase from the previous quarter (Q1 2024), and a -3.19% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.01B, a -0.19% decrease from the previous quarter (Q4 2023), and a -1.73% decrease year-over-year (Q1 2023). CRL's quarterly revenue for Q4 2023 was $1.01B, a -1.28% decrease from the previous quarter (Q3 2023), and a -7.85% decrease year-over-year (Q4 2022).

What is Charles River Laboratories’s revenue growth rate?

Charles River Laboratories's revenue growth rate for the last 3 years (2022-2024) was 1.86%, and for the last 5 years (2020-2024) was 38.51%.

What are Charles River Laboratories’s revenue streams?

Charles River Laboratories's revenue streams in c 24 are Manufacturing Support, Discovery and Safety Assessment, and Research Models and Services. Manufacturing Support generated $769.33M in revenue, accounting 19.00% of the company's total revenue, up 6.64% year-over-year. Discovery and Safety Assessment generated $2.45B in revenue, accounting 60.53% of the company's total revenue, down -6.28% year-over-year. Research Models and Services generated $829.38M in revenue, accounting 20.48% of the company's total revenue, up 4.67% year-over-year.

What is Charles River Laboratories’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Charles River Laboratories was Discovery and Safety Assessment. This segment made a revenue of $2.45B, representing 60.53% of the company's total revenue.